MBOAT2
Membrane-bound glycerophospholipid O-acyltransferase 2
Also known as: FLJ14415, FLJ90298, LPLAT13, MBOA2_HUMAN, OACT2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZWT7
- Gene
- MBOAT2
- Ensembl
- ENSG00000143797
- Chromosome
- 2
- Canonical length
- 520 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables 1-acylglycerophosphocholine O-acyltransferase activity; 1-acylglycerophosphoethanolamine O-acyltransferase activity; and 1-acylglycerophosphoserine O-acyltransferase activity. Involved in phosphatidylcholine acyl-chain remodeling; phosphatidylethanolamine acyl-chain remodeling; and phosphatidylserine acyl-chain remodeling. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
520 residues, UniProt reviewed canonical sequence.
>Q6ZWT7|MBOAT2
1 MATTSTTGST LLQPLSNAVQ LPIDQVNFVV CQLFALLAAI WFRTYLHSSK TSSFIRHVVA
61 TLLGLYLALF CFGWYALHFL VQSGISYCIM IIIGVENMHN YCFVFALGYL TVCQVTRVYI
121 FDYGQYSADF SGPMMIITQK ITSLACEIHD GMFRKDEELT SSQRDLAVRR MPSLLEYLSY
181 NCNFMGILAG PLCSYKDYIT FIEGRSYHIT QSGENGKEET QYERTEPSPN TAVVQKLLVC
241 GLSLLFHLTI CTTLPVEYNI DEHFQATASW PTKIIYLYIS LLAARPKYYF AWTLADAINN
301 AAGFGFRGYD ENGAARWDLI SNLRIQQIEM STSFKMFLDN WNIQTALWLK RVCYERTSFS
361 PTIQTFILSA IWHGVYPGYY LTFLTGVLMT LAARAMRNNF RHYFIEPSQL KLFYDVITWI
421 VTQVAISYTV VPFVLLSIKP SLTFYSSWYY CLHILGILVL LLLPVKKTQR RKNTHENIQL
481 SQSKKFDEGE NSLGQNSFST TNNVCNQNQE IASRHSSLKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MBOAT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 28 nTPM
- bone marrow: 25 nTPM
- choroid plexus: 21 nTPM
- spinal cord: 19 nTPM
- cerebral cortex: 17 nTPM
- midbrain: 16 nTPM
Single-cell type
- esophageal apical cells: 1,372 nCPM
- salivary duct cells: 713 nCPM
- neutrophil progenitors: 667 nCPM
- neutrophils: 645 nCPM
- erythrocyte progenitors: 619 nCPM
- esophageal suprabasal cells: 523 nCPM
Immune cell
- basophil: 4.7 nTPM
- neutrophil: 4 nTPM
- eosinophil: 1.7 nTPM
- classical monocyte: 0.4 nTPM
- myeloid DC: 0.4 nTPM
- total PBMC: 0.2 nTPM
Brain region
- white matter: 57 nTPM
- choroid plexus: 53 nTPM
- basal ganglia: 46 nTPM
- midbrain: 45 nTPM
- thalamus: 44 nTPM
- hypothalamus: 44 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.52
- gnomAD missense Z
- 1.7
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lipid modification
- phosphatidylcholine acyl-chain remodeling
- phosphatidylethanolamine acyl-chain remodeling
- phosphatidylserine acyl-chain remodeling
- phospholipid biosynthetic process
- regulation of chondrocyte differentiation
Molecular functions
- 1-acylglycerol-3-phosphate O-acyltransferase activity
- 1-acylglycerophosphocholine O-acyltransferase activity
- 1-acylglycerophosphoethanolamine O-acyltransferase activity
- 1-acylglycerophosphoserine O-acyltransferase activity
- 2-acylglycerol-3-phosphate O-acyltransferase activity
- acyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MBOAT2 as an antibody target. Whether an autoantibody or antibody against MBOAT2 could matter depends on whether native MBOAT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MBOAT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MBOAT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...